Pathophysiology of the burn wound and pharmacological treatment. The Rudi Hermans Lecture, 1995

Burns

Volumn 22, Issue 4, 1996, Pages 255-274

  Arturson, G ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; CYTOKINE; INDOMETACIN; MELILOTUS EXTRACT; MONOXERUTIN; OXYGEN RADICAL; PHENYLBUTAZONE; STEROID; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOXANE SYNTHASE INHIBITOR;

BURN; CHEMOPROPHYLAXIS; EXCISION; HOST RESISTANCE; HUMAN; PERMEABILITY; REVIEW; SEPSIS; TOPICAL DRUG ADMINISTRATION; VASCULARIZATION; WOUND CARE;

EID: 0029934690     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/0305-4179(95)00153-0     Document Type: Article

References (252)

1. Arturson G. Possible involvement of arachidonic acid metabolites in thermal trauma. In: Dolecek R, Brizio-Molteni L, Traber D, eds. Endocrinology of Thermal Trauma: pathophysiologic mechanisms and clinical interpretation. Philadelphia: Lea & Febiger, 1990; p 238.
2. Barlow Y. T lymphocytes and immunosuppression in the burned patient: a review. Burns 1994; 20: 487.
3. Arturson G. Pathophysiological aspects of the burn syndrome with special reference to liver injury and alterations of capillary permeability. Acta Chir Scand (Suppl) 1961; 274: 55.
4. Beal A, Cerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994; 271: 226.
5. Ashbaugh DG, Bigelow DB, Petty TL et al. Acute respiratory distress in adults. Lancet 1967; ii: 319.
6. Carrico CJ, Meakins JL, Marshall JC et al. Multiple-organ-failure syndrome. Arch Surg 1986; 121: 196.
7. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644.
8. Cioffi WG, Burleson DG, Pruitt Jr BA. Leukocyte responses to injury. Arch Surg 1993; 128: 1260.
9. Haglund U, Gerdin B. Trends in shock research. Oxygen-free radicals (OFR) and circulatory shock. Circ Shock 1991; 34: 405.
10. Demling RH, Lalonde C. Lipid peroxidation and inflammation inflicted by thermal injury persists into the post resuscitation period. J Trauma 1990; 30: 69.
11. Gerdin B, Haglund U. Possible involvement of oxygen free radicals in shock and shock-related states. In: Neugebauer EA, Holaday JW, eds. Handbook of Mediators in Septic Shock. Boca Raton, FL: CRC Press, 1993; p 457.
12. Kaufman T, Neuman RA, Weinberg A. Is postburn dermal ischaemia enhanced by oxygen free radicals? Burns 1989; 15:291.
13. Hiramatsu M, Izawa Y. Serum lipid peroxide levels of patients suffering from thermal injury. Burns 1984; 11: 111.
14. Thomson PD, Till GO, Woolliscroft JO et al. Superoxide dismutase prevents lipid peroxidation in burned patients. Burns 1990; 16: 406.
15. Kumar R, Seth RK, Sekhon MS et al. Serum lipid peroxide and other enzyme levels of patients suffering from thermal injury. Burns 1995; 21: 96.
16. Saez JC, Ward PH, Gunther B et al. Superoxide radical involvement in the pathogenesis of burn shock. Circ Shock 1984; 12: 229.
17. Till GO, Hatherill JR, Tourtellotte WW et al. Lipid peroxidation and acute lung injury after thermal trauma to skin. Evidence of a role for hydroxyl radical. Am J Pathol 1985; 119: 376.
18. Jackson D. Mac G. The William Gissane Lecture 1982. The burn wound: its character, closure and complications. Burns 1983; 10: 1.
19. Arturson G, Mellander S. Acute changes in capillary filtration and diffusion in experimental burn injury. Acta Physiol Scand 1964; 62: 457.
20. Nozaki ML, Guest MM, Bond TP et al. Permeability of blood vessels after thermal injury. Burns 1979; 6: 213.
21. Arturson G: Microvascular permeability of macromolecules in thermal injury. Acta Physiol Scand 1979; 463: (suppl), 111.
22. Lund T, Onarheim G, Wiig H et al. Mechanisms behind the increased dermal inhibition pressure in acute burn edema. Am J Physiol 1989; 256: H940.
23. Zawacki BE. The natural history of reversible burn injury. Surg Gynecol Obstet 1974; 139: 867.
24. 2 integrins in vivo. Proc Nat Acad Sci 1991; 88: 7538.
25. Luttherman A, Dacso CC, Curreri PW. Infections in burn patients. Am J Med 1986; 81: (suppl IA), 45.
26. Mooney DP, Gamelli RL. Sepsis following thermal injury. Comp Ther 1989; 15: 22.
27. Mozingo DW, Pruitt Jr BA. Infectious complications after burn injury. Curr Opin Surg Infed 1994; 2: 69.
28. Pruitt Jr BA, McManus AT. The changing epidemiology of infection in burn patients. World J Surg 1992; 16: 57.
29. Vindenes H, Bjerknes R. The frequency of bacteremia and fungemia following wound cleaning and excision in patients with large burns. J Trauma 1993; 35: 742.
30. Roitt I, Brostoff J, Male D. Immunology, 3rd edn. London: Mosby, 1993.
31. Kurkinen DR, Vaheri A, Roberts PJ et al. Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest 1980; 43: 47.
32. Leibovich SJ. Mesenchymal cell proliferation in wound repair: the role of macrophages. In: Hunt TK, Heppenstall RB, Pines E et al, eds. Soft and Hard Tissue Repair. New York: Praeger, 1984; p 36.
33. Deuel TF, Senior RM, Chang D et al. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Nail Acad Sci USA 1981; 78: 4584.
34. Schiffman E, Showell HV, Corcoran BA et al. The isolation and partial characterisation of neutrophil chemotactic factors from E. coli. J Immunol 1975; 114: 1831.
35. Knighton DR, Hunt TK, Scheuenstuhl H et al. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 1983; 221: 1283.
36. Jensen JA, Hunt TK, Scheuenstuhl H et al. Effect of lactate, pyruvate and pH on secretion of angiogenesis and mitogenesis factors by macrophages. Lab Invest 1986; 54: 574.
37. Dziewulski P. Burn wound healing: James Ellsworth Laing Memorial Essay for 1991. Burns 1992; 18: 466.
38. Hansbrough JF, Zapata-Sirvent R, Hoyt D. Postburn immune suppression: an inflammatory response to the burn wound. J Trauma 1990; 30: 671.
39. Edery H, Lewis GP. Kinin-forming activity and histamine in lymph after tissue injury. J Physiol (Lond) 1963; 169: 568.
40. Arturson G. The plasma kinins in thermal injury. Scand J Clin Lab Invest 1969; 24: (suppl 107), 153.
41. Zachariae E, Henningsen S, Juel et al. Plasma kinins in inflammation - relation to other mediators and leukocytes. Scand J Clin Lab Invest 1969; 107: (suppl), 85.
42. Holder IA, Neely AN. Hageman factor-dependent kinin activation in burns and its theoretical relationship to postburn immunosuppression syndrome and infection. J Burn Care Rehabil 1990; 11: 496.
43. Zimmerman TJ, Krizek TJ. Thermally induced dermal injury: a review of pathophysiologic events and therapeutic intervention. J Burn Care Rehabil 1984; 5: 193.
44. Adam A, Damas J, Albert A et al. Plasma prekallikrein and kininogen in burned patients. Thromb Res 1986; 41: 537.
45. Arturson G, Rammer L. Endogenous inhibition of fibrinoly-sis in patients with severe burns. Acta Chir Scand 1974; 140: 181.
46. Rockwell WB, Ehrlich HP. Fibrinolysis inhibition in human burn blister fluid. J Burn Care Rehabil 1990; 11: 1.
47. Fjellström KE, Arturson G. Changes in the human complement system following burn trauma. Acta Pathol Microbiol Scand 1963; 59: 257.
48. Lowbury EJL, Ricketts CR. Properdin and the defence of burns against infection. J Hygiene 1957; 55: 266.
49. Gelfand JA, Donelan M, Burke JF. Preferential activation and depletion of the alternative complement pathway by burn injury. Ann Surg 1983; 198: 58.
50. Oldham KT, Gwice KS, Till GO et al. Activation of complement by hydroxyl radical in thermal injury. Surgery 1988; 104: 272.
51. Björnson AB, Altemeier WA, Björnson HS. Complement opsonins, and the immune response to bacterial infection in burned patients. Ann Surg 1980; 191: 323.
52. Gelfand JA, Donelan M, Harviger A et al. Alternative complement pathway activation increases mortality in a model of burn injury in mice. J Clin Invest 1982; 70: 1170.
53. Solomkin JS, Nelson RD, Chenoweth DE et al. Regulation of neutrophil migratory function in burn injury by complement activation products. Ann Surg 1984; 200: 742.
54. Moore FD, Davis C, Rodrick M et al. Neutrophil activation in thermal injury as assessed by increased expression of complement receptors. N Engl J Med 1986; 314: 948.
55. Davis JM, Moore FD, Rodrick ML et al. Neutrophil activation after burn injury: contribution of the classic complement pathway and of endotoxin. Surg 1987; 102: 477.
56. Vindenes H, Bjerknes R. Activation of polymorphonuclear neutrophilic granulocytes following burn injury: alteration of Fc-receptor and complement-receptor expression and of opsonophagocytosis. J Trauma 1994; 36: 161.
57. Sevitt S. Pathological sequele of burns. Local vascular changes in burned skin. Proc R Soc Med 1954; 47: 225.
58. Jonsson CE, Brodin E, Dalsgaard CJ et al. Release of substance P-like immunoreactivity in dog paw lymph after scalding injury. Acta Physiol Scand 1986; 126: 21.
59. Löfgren O, Lundeberg T. Calcitonin gene-related peptide reduces thermally induced oedema in the rat paw. Neurosci Lett 1994; 1: 1.
60. Arturson G. The pathophysiology of severe thermal injury. J Burn Care Rehabil 1985; 6: 129.
61. Friedl HP, Till GO, Trentz O et al. Roles of histamine, complement and xanthine oxidase in thermal injury of skin. Am J Pathol 1989; 135: 203.
62. Lavaud P. Mathieu J. Bienvenu P et al. Modulation of leukocyte activation in the early phase of the rabbit burn injury. Burns 1988; 14: 15.
63. Schenfeld W, Kasimir S, Koeller M et al. Metabolism of platelet activating factor (PAF) and lyso-PAF in polymorphonuclear granulocytes from severely burned patients. J Trauma 1990; 30: 1554.
64. Bellomo R. The cytokine network in the critically ill. Anaesth Intens Care 1992; 20: 288.
65. Lowry SF. Cytokine mediators of immunity and inflammation. Arch Surg 1993; 128: 1235.
66. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627.
67. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993; 328: 106.
68. Arend WP. Interleukin-1 receptor antagonist. Adv Immunol 1993; 54: 167.
69. Arend WP, Welgus HG, Thompson RC et al. Biological properties of recombinant human monocyte-derived interleukin-1 receptor antagonist. J Clin Invest 1990; 85: 1694.
70. Cannon JG, Friedberg JS, Gelfand JA et al. Circulating interleukin-1β and tumor necrosis factor-a concentrations after burn injury in humans. Crit Care Med 1992; 20: 1414.
71. Drost AC, Burleson DG, Cioffi WG et al. Plasma cytokines following thermal injury and their relationship with mortality, burn size, and time postburn. J Trauma 1993; 35: 335.
72. Vindenes H. Host Defence and Inflammation in Patients with Large Burns. Bergen: Doves Trykkeri AS, 1994.
73. Monge G, Sparkes BG, Allgöwer M et al. Influence of burn-induced lipid-protein complex on IL-1 secretion by PBMC in vitro. Burns 1991; 17: 269.
74. Lin X-S, Yang Z-C, Luo Z-H et al. Clinical significance of the change of blood monocytic interleukin-1 production in vitro in severely burned patients. Burns 1994; 20: 302.
75. Teodorczyk-Injeyan JA, Sparkes BG, Mills GB et al. Soluble interleukin 2-receptor a secretion is related to altered interleukin 2 production in thermally injured patients. Burns 1991; 17: 290.
76. Teodorczyk-Injeyan JA, Sparkes BG, Lalani S et al. IL-2 regulation of soluble IL-2 receptor levels following thermal injury. Clin Exp Immunol 1992; 90: 36.
77. Teodorczyk-Injeyan JA, Sparkes BG, Peters WJ. Regulation of IgM production in thermally injured patients. Burns 1989; 15: 241.
78. Guo Y, Dickerson C, Chrest FJ et al. Increased levels of circulating interleukin-6 in burn patients. Clin Immunol Immunopathol 1990; 54: 361.
79. Schluter B, Kønig B, Bergmann U et al. Interleukin 6 - A potential mediator of lethal sepsis after major thermal trauma: evidence of increased IL-6 production by peripheral blood mononuclear cells. J Trauma 1991; 31: 1663.
80. Ono I, Gunji H, Zhang J-Z et al. A study of cytokines in burn blister fluid related to wound healing. Burns 1995; 21: 352.
81. Schindler R, Mancilla J, Endres S et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1 and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990; 75: 40.
82. Schröder J-M, Christophers E. The biology of NAP-1/IL-8, a neutrophil-activating cytokine. Immunol Series 1992; 57: 387.
83. Schröder J-M, Mrowietz U, Morita E et al. Purification and partial biochemical characterization of a human monocyte-derived neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol 1987; 139: 3474.
84. Gimbrone MA, Obin MS, Brock AF et al. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science 1989; 246: 1601.
85. Larsen CG, Anderson AO, Oppenheim JJ et al. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumor necrosis factor. Immunology 1989; 68: 31.
86. Bazzoni F, Cassatella MA, Rossi F et al. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/Interleukin 8. J Exp Med 1991; 173: 771.
87. Peveri P. Walz A, Dewald B et al. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988; 167: 1547.
88. Detmers PA, Powell DE, Walz A et al. Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. J Immunol 1991; 147: 4211.
89. Smith WB, Gamble JR, Clarke-Lewis I et al. Interleukin-8 induces neutrophil transendothelial migration. Immunology 1991; 72:65.
90. Vindenes H, Ulvestad E, Bjerknes R. Increased levels of circulating interleukin-8 in patients with large burns: relation to burn size and sepsis. J Trauma 1995; 39: 635.
91. Tracey KJ, Cerami A. Tumor necrosis factor: an update review of its biology. Crit Care Med 1993; 21: 415.
92. Klebanoff SJ, Vadas MA, Harlan JM et al. Stimulation of neutrophils by tumor necrosis factor. J. Immunol 1986; 136: 4220.
93. Damas P, Reuter A. Gysen P et al. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17: 975.
94. Farriol M, Schwartz S, Rosello J et al. Epidermal growth factor excretion in burned rats. Burns 1994; 20: 496.
95. Endo S, Inada K, Yamada Y et al. Plasma tumour necrosis factor-α (TNF-α) levels in patients with burns. Burns 1993; 19: 124.
96. Liu X-S, Luo Z-H, Yang Z-C et al. The significance of changes of serum tumor necrosis factor (TNF) activity in severely burned patients. Burns 1993; 20: 40.
97. Liu X-S, Yang Z-C, Luo Z-H et al. A preliminary exploration of the relationship between tumour necrosis factor (TNF) and monocytic in vitro production of interleukin-1 (IL-1) and internal organ dysfunction in severely burned patients. Burns 1995; 21: 29.
98. Peruccio D, Castagnoli C, Stella M et al. Altered biosynthesis of tumour necrosis factor (TNF) alpha is involved in postburn hypertrophic scars. Burns 1994; 20: 118.
99. Grayson LS, Hansbrough JF, Zapata-Sirvent RL et al. Quantitation of cytokine levels in skin graft donor site wound fluid. Burns 1993; 19: 401.
100. Suzuki F, Pollard RB. Alterations of interferon production in a mouse model of thermal injury. J Immunol 1982; 129: 1806.
101. Livingston D, Appel S, Wellhausen S et al. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg 1988; 123: 1309.
102. Gennari R, Alexander JW, Eaves-Pyles T. IFN-γ decreases translocation and improves survival following transfusion and thermal injury. J Surg Res 1994; 56: 530.
103. Balogh D, Lammer H, Kornberger E et al. Neopterin plasma levels in burn patients. Burns 1992; 18: 185.
104. Grabosch A, Rokos H. Neopterin as parameter of cell-mediated immunity response in thermally injured patients. Burns 1992; 18: 113.
105. McGrath MH. Peptide growth factors and wound healing. Clin Plast Surg 1990; 17: 421.
106. Møller S, Jensen M, Svensson P et al. Insulin-like growth factor 1 (IGF-1) in burn patients. Burns 1991; 17: 279.
107. Cioffi WG, Gore DC, Rue LW et al. Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury. Ann Surg 1994; 220: 310.
108. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today 1990; 11: 458.
109. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993; 91: 379.
110. Ruoslahti E. Integrins. J Clin Invest 1991; 87: 1.
111. Muller WA, Weigl SA, Deng X et al. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178: 449.
112. Alexander JW, Wixson D. Neutrophil dysfunction and sepsis in burn injury. Surg Gynecol Obstet 1970; 130: 431.
113. Curreri PW, Heck EL, Browne L et al. Stimulated nitroblue tetrazolium test to assess neutrophil antibacterial function: prediction of wound sepsis in burned patients. Surgery 1973; 74: 6.
114. Grogan JB, Miller RC. Impaired function of polymorphonuclear leukocytes in patients with burns and other trauma. Surg Gynecol Obstet 1973; 137: 784.
115. Warden GD, Mason AD, Pruitt BA Jr. Evaluation of leukocyte chemotaxis in vitro in thermally injured patients. J Clin Invest 1974; 54: 1001.
116. Heck EL, Brown L, Curreri PW et al. Evaluation of leukocyte function in burned individuals by in vitro oxygen consumption. J Trauma 1975; 15: 486.
117. Grogan JB. Altered neutrophil phagocytic function in burn patients. J Trauma 1976; 16: 734.
118. Grogan JB. Suppressed in vitro chemotaxis of burn neutrophils. J Trauma 1976; 16: 985.
119. Ransjö U, Forsgren A, Arturson G. Neutrophil leucocyte functions and wound bacteria in burn patients. Burns 1977; 31: 171.
120. Heideman M, Kaijser B, Gelin LE. Complement activation and hematologic, hemodynamic, and respiratory reactions early after soft-tissue injury. J Trauma 1978; 18: 696.
121. Heck EL, Edgar MA, Masters BS et al. The role of NADH-NADPH oxidase activity in the leukocyte function of burned patients. J Trauma 1979; 19: 49.
122. Ransjö U, Arturson G. Håkansson L et al. Some aspects of neutrophil granulocyte function in burn patients. Burns 1979; 5: 255.
123. Davis JM, Dineen P, Gallin JI. Neutrophil degranulation and abnormal chemotaxis after thermal injury. J Immunol 1980; 124: 1467.
124. Heck E, Edgar MA, Hunt JL et al. A comparison of leukocyte function and burn mortality. J Trauma 1980; 20: 75.
125. Van Epps DE, Garcia ML. Enhancement of neutrophil function as a result of prior exposure to chemotactic factor. J Clin Invest 1980; 66: 167.
126. Venge P, Arturson G. Locomotion of neutrophil granulocytes from patients with thermal injury. Identification of serum-derived inhibitors. Burns 1981; 8: 6.
127. Allen RC, Pruitt BA Jr. Humoral-phagocyte axis of immune defense in burn patients. Chemoluminigenic probing. Arch Surg 1982; 117: 133.
128. Arturson G. Arachidonic acid metabolism and prostraglandin activity following burn injury. In: Ninnemann JL, ed. Traumatic Injury. Infection and other immunologic sequelae. Baltimore: University Park Press, 1983; p 57.
129. Heggers JP, Robson MC. Prostaglandins and thromboxanes. In: Ninnemann JL, ed. Traumatic Injury. Infection and other immunologic sequelae. Baltimore: University Park Press, 1983; p 79.
130. McManus AT. Examination of neutrophil function in a rat model of decreased host resistance following burn trauma. Infect Dis 1983; 5: 898.
131. Till GO, Beauchamp C, Menapace D et al. Oxygen radical dependent lung damage following thermal injury of rat skin. J Trauma 1983; 23: 269.
132. Deitch E. The relationship between thermal injury and neutrophil membrance functions as measured by chemotaxis, adherence and spreading. Burns 1984; 10: 264.
133. Schmidt K, Bruchelt G, Kistler L et al. Phagocytic activity of granulocytes and alveolar macrophages after burn injury measured by chemiluminescence. Burns 1983; 10: 79.
134. Arturson G. Neutrophil granulocyte functions in severely burned patients. Burns 1985; 11: 309.
135. Duque RE, Phan SH, Hudson JL et al. Functional defects in phagocytic cells following thermal injury. Am J Pathol 1985; 118: 116.
136. El-Falaky MH, Abdel-Hafez A, Houtah AH. Phagocytic activity of polymorphonuclear leukocytes in burns. Burns 1985; 11: 185.
137. Deitch EA, Landry KN. Neutrophil subpopulations change after thermal injury. J Trauma 1986; 26: 534.
138. Nelson RD, Hasslen SR, Ahrenholz DH et al. Influence of minor thermal injury on expression of complement receptor CR3 on human neutrophils. Am J Pathol 1986; 125: 563.
139. Nelson RD, Hasslen SR, Ahrenholz DH et al. Mechanisms of loss of human neutrophil chemotaxis following thermal injury. J Burn Care Rehabil 1987; 8: 496.
140. Bjerknes R, Hallvard V, Pitkanen J et al. Altered polymorphonuclear neutrophilic granulocyte functions in patients with large burns. J Trauma 1989; 29: 847.
141. Björnson AB, Knippenberg RW, Björnson HS. Bactericidal defect of neutrophils in a guinea pig model of thermal injury is related to elevation of intracellular cyclic-3′5-adenosine monophosphate. J Immunol 1989; 143: 2609.
142. Dobke MK, Deitch EA, Harnar TJ et al. Oxidative activity of polymorphonuclear leukocytes after thermal injury. Arch Surg 1989; 124: 856.
143. Kim Y, Goldstein E, Lippert W et al. Polymorphonuclear leucocyte mobility in patients with severe burns. Burns 1989; 15: 93.
144. D'Alesandro MM, Gruber DF. Quantitative and functional alterations of peripheral blood neutrophils after 10% and 30% thermal injury. J Burn Care Rehabil 1990; 11: 295.
145. Ogle CK, Alexander JW, Nagy H et al. A long-term study and correlation of lymphocyte and neutrophil function in the patient with burns. J Burn Care Rehabil 1990; 11: 105.
146. Benhaim P, Hunt TK. Natural resistance to infection: leukocyte function. J Burn Care Rehabil 1992; 13: 287.
147. Cioffi WG Jr, Burleson DG, Jordan BS et al. Granulocyte oxidative activity following thermal injury. Surgery 1992; 112: 860.
148. Hasslen SR, Ahrenholz DH, Solem LD et al. Actin polymerization contributes to neutrophil chemotactic dysfunction following thermal injury. J Leukoc Biol 1992; 52: 495.
149. Pralat V, Lips V, Pallua N et al. Altered neutrophil function in patients with major burn trauma. Ann Medit Burns Club 1994; VII: 131.
150. Klebanoff SJ, Clark RA. The Neutrophil: Function and Clinical Disorders. Amsterdam: North-Holland, 1978; p 409.
151. Herndon DN, Langner F, Thompson P et al. Pulmonary injury in burned patients. Surg Clin North Am 1987; 67: 31.
152. Zapata-Sirvent RL, Hansbrough JF. Temporal analysis of human leukocyte surface antigen expression and neutrophil respiratory burst activity after thermal injury. Burns 1993; 19:5.
153. de Chalain TMB, Bracher M, Linley W et al. Cytoskeletal actin: the influence of major burns on neutrophil structure and function. Burns 1994; 20: 416.
154. Änggård E, Arturson G, Jonsson CE. Efflux of prostaglandins in lymph from scalded tissues. Acta Physiol Scand 1970; 80: 46A.
155. Jonsson CE. Prostaglandins in burn injury. Acta Univ Upsal 1972; 134: 1.
156. Hamberg M, Jonsson CE. Increased synthesis of prostaglandins in the guinea pig following scalding injury. Acta Physiol Scand 1973; 87: 240.
157. Arturson G. Prostaglandins in human burn wound secretion. Burns 1977; 3: 112.
158. Jonsson CE, Granström E, Hamberg M. Prostaglandins and thromboxanes in burn injury in man. Scand J Plast Reconstr Surg 1979; 13: 45.
159. 2 in leg lymph of rabbits after scalding injury. Acta Physiol Scand 1979; 107:377.
160. Alexander F. Arachidonic acid metabolites mediate early burn edema. J Trauma 1984; 24: 709.
161. Harms BA, Bodai B, Smith M et al. Prostaglandin release and altered micro vascular integrity after burn injury. J Surg Res 1981; 31:274.
162. Zweifach BW. Dynamic sequelae of the acute inflammatory process. A state-of-the-art review. In: Little RA, Frayn KN, eds. The Scientific Basis for the Care of the Critically Ill. Manchester: Manchester University Press, 1986.
163. Arturson G, Hamberg M, Jonsson CE. Prostaglandins in human burn blister fluid. Acta Physiol Scand 1973; 87: 270.
164. Sugisama S, Norimatsu I, Kobayashi M. Prostaglandins released in human burn blister fluid. Biomedicine 1978; 29: 51.
165. Whittle BJR, Moncada S. Pharmacological interactions between prostacyclin and thromboxanes. Br Med Bull 1983; 39: 232.
166. Heggers JP, Ko F, Robson MC. Evaluation of burn blister fluid. Reconstr Surg Traumatol 1980; 65: 798.
167. Heggers JP, Loy GL, Robson MC et al. Histological demonstration of prostaglandins and thromboxanes in burned tissue. J Surg Res 1980; 28: 110.
168. Robson MC, Del Beccaro EJ, Heggers JP et al. Increasing dermal perfusion after burning by decreasing thromboxane production. J Trauma 1980; 20: 772.
169. Dobke MK, Hayes EC, Baxter CR. Leukotrienes LTB4 and LTC4 in thermally injured patients' plasma and burn blister fluid. J Burn Care Rehabil 1987; 8: 189.
170. Köller M, König W, Brom J et al. Generation of leukotrienes from human polymorphonuclear granulocytes of severely burned patients. J Trauma 1988; 28: 733.
171. Köller M, König W, Brom J et al. Studies on the mechanisms of granulocyte dysfunctions in severely burned patients -evidence for altered leukotriene generation. J Trauma 1989; 29: 435.
172. Rappaport FT, Converse JM, Horn L et al. Altered reactivity to skin homografts in severe thermal injury. Ann Surg 1964; 159: 390.
173. Wolfe JHN, Wu AVO, O'Connor NE et al. Anergy, immunosuppressive serum and impaired lymphocyte blastogenesis in burn patients. Arch Surg 1982; 117: 1266.
174. Hansbrough JF, Bender EM, Zapata-Sirvent RL et al. Altered helper and suppressor lymphocyte populations in surgical patients. A measure of post operative immunosuppression. Am J Surg 1984; 148: 303.
175. Organ BC, Antonacci AC, Chiao J et al. Changes in lymphocyte numbers and phenotype in seven lymphoid compartments after thermal injury. Ann Surg 1989; 210: 78.
176. Wood JJ, Rodrick M, O'Mahony J et al. Inadequate interleukin-2 production: a fundamental immunological deficiency in patients with major burns. Ann Surg 1984; 200: 311.
177. O'Riordain DS, Mendex MV, O'Riordain MG et al. Molecular mechanisms of decreased interleukin-2 production after thermal injury. Surgery 1993; 114: 407.
178. Gadd MA, Hansbrough JF, Hoyt DA et al. Defective T-cell surface antigen expression after mitogen stimulation. Ann Surg 1989; 20: 112.
179. Schluter B, Konig W, Koller M et al. Differential regulation of T and B lymphocyte activation in severely burned patients. J Trauma 1991; 31: 239.
180. Teodorczyk-Injeyan JA, Sparkes BG, Mills GB et al. Immunosuppression follows systemic T lymphocyte activation in the burn patient. Clin Exp Med 1991; 85: 515.
181. Hansbrough JF, Gadd MA. Temporal analysis of murine lymphocyte subpopulations by monoclonal antibodies and dual-colour flow cytometry after burn and non burn injury. Surgery 1989; 106: 69.
182. McIrvine AJ, O'Mahony JB, Saporoschetz I et al. Depressed immune response in burn patients: use of monoclonal antibodies and functional assays to define the role of suppressor cells. Ann Surg 1982; 196: 297.
183. Maldonado MD, Venturoli A, Franco A et al. Specific changes in peripheral blood lymphocyte phenotype from burn patients. Probable origin of the thermal injury-related lymphocytopenia. Burns 1991; 17: 188.
184. Schluter B, Konig W, Koller M et al. Studies on B-lymphocyte dysfunctions in severely burned patients. J Trauma 1990; 30: 1380.
185. Rodrick ML, Wood JJ, Mahony JB et al. Defective IL-2 production in patients with severe burns and sepsis. Lymphokine Res 1986; 5: (suppl 1), S75.
186. Xiao GX, Chopra RK, Adler W et al. Altered expression of lymphocyte IL-2 receptors in burned patients. J Trauma 1988; 28: 1669.
187. Vaughan GM, Becker RA, Allen JP et al. Cortisol and corticotrophin in burned patients. J Trauma 1982; 22: 263.
188. Calvano SE, Albert JD, Legaspi A et al. Comparison of numerical and phenotypic leukocyte changes during constant hydrocortisone infusion in normal humans with those in thermally injured patients. Surg Gynecol Obstet 1987; 164: 509.
189. Richardson RP, Rhyne CD, Fong Y et al. Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects: influence of elicited hormones and cytokines. Ann Surg 1989; 210: 239.
190. Calvano SE, Barber AE, Hawes AS et al. Effect of combined cortisolendotoxin administration on peripheral blood leukocyte counts and phenotype in normal humans. Arch Surg 1992; 127: 181.
191. Hoffman RA, Hansen WP. Immunofluorescent analysis of blood cells by flow cytometry. Int J immunopharmacol 1981; 3: 249.
192. Rollof J. Immunförsvaret - funktion och terapimöjligheter. Studentlitt., Lund, 1995.
193. Burleson DG, Vaughan GK, Mason AD Jr et al. Flow cytometric measurements of rat lymphocyte subpopulations after burn injury and burn injury with infection. Arch Surg 1987; 22: 216.
194. Burleson DG, Mason AD Jr, Pruitt BA Jr. Lymphoid subpopulation changes after thermal injury and thermal injury with infection in an experimental model. Ann Surg 1988; 207: 208.
195. Gough DB, Jordan A, Collins K et al. Suppressor T-cell levels are unreliable indicators of the impaired immune response following thermal injury. J Trauma 1992; 32: 677.
196. Rioja LF, Alonso P, de Haro J et al. Prognostic value of the CD4/CD8 lymphocyte ratio in moderately burned patients. Burns 1993; 19: 198.
197. Billiau A, Vandekerckhove F. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Clin Invest 1991; 21: 559.
198. Yurt RW, Shires GT. Increased susceptibility to infection due to infusion of exogenous chemotaxin. Arch Surg 1987; 122: 111.
199. Green DR, Wang N, Zheng H. A suppressor-inducer factor produced by burn trauma-associated T cells. J Burn Care Rehabil 1987; 8: 521.
200. Schoenberger GA. Burn toxins isloated from mouse and human skin. Their characterisation and immunotherapy effects. Monogr Allergy 1975; 9: 72.
201. Ninneman JA, Stein MD. Suppression of in vitro lymphocyte response by burn toxin isolates from thermal injured skin. Immunol Lett 1981; 2: 339.
202. Sparkes BG, Teodorcyzk-Injeyan JA, Peters WJ. Mediators affecting IL-2 function in burn immunosuppression. In: Paubert-Braquet M, ed. Lipid Mediators in the Immunology of Shock. NATO ASI Series. New York: Plenum, 1987; p 337.
203. Sparkes BG, Gyorkos JW, Gorczynski RM et al. Comparison of endotoxins and cutaneous burn toxin as immunosuppressants. Burns 1990; 16: 123.
204. Sparkes BG. Influence of burn induced lipid-protein complex on IL-2 secretion by PBMC in vitro. Burns 1991; 17: 128.
205. Sevitt S. The failure of antihistamine drugs to influence the local vascular changes in experimental burns. Br J Exp Pathol 1949; 30: 540.
206. Sevitt S, Bull JP, Cruickshank CND et al. Failure of an antihistamine drug to influence the course of experimental human burns. Br Med J 1952; 2: 57.
207. Arturson G. Anti-inflammatory drugs and burn edema formation. In: May R, Dogo G, eds. Care of the Burn Wound. Basel: Karger, 1985; p 49.
208. Boykin JV, Crute SL, Haynes BW. Cimetidine therapy for bum shock: a quantitative assessment. J Trauma 1985; 25: 864.
209. Tanaka H, Wada T, Simazaki S et al. Effects of cimetidine on fluid requirement during resuscitation of third-degree burns. J Burn Care Rehabil 1991; 12: 425.
210. Arturson G. Effects of O-(β-hydroxyethyl)-rutosides (HR) on the increased microvascular permeability in experimental skin burns. Acta Chir Scand 1972; 138: 111.
211. Arturson G, Jonsson CE. Effects of O-(hydroxyethyl)-rutosides (HR) and indomethacin on transcapillary macromolecular transport and prostaglandins following scalding injury. Bibliotheca Anat 1973; 12: 465.
212. Piller NB. Further evidence for the induction of proteolysis by coumarin in rats with various high protein oedemas. Folia Angiol 1976; 27: 860.
213. Piller NB. A conservative means of reducing the intensity and duration of thermally induced oedema. Burns 1976; 2: 143.
214. Kuehl FA, Egan RW. Prostaglandins, arachidonic acid, and inflammation. Science 1980; 210: 978.
215. Hilton JG. Effects of alterations of polyunsaturated fatty acid metabolism upon plasma volume loss induced by thermal trauma. J Trauma 1980; 20: 663.
216. Arturson G, Jonsson CE. Effects of indomethacin on the transcapillary leakage of macromolecules and the efflux of prostaglandins in the paw lymph following experimental scalding injury. Ups J Med Sci 1973; 78: 181.
217. Robson MC, Kucan JO, Paik KI et al. Prevention of dermal ischemia following thermal injury. Arch Surg 1978; 113: 621.
218. Robson MC, Del Beccaro EJ, Heggers JP. The effect of prostaglandin in the dermal microcirculation after burning and the inhibition of the effect by specific pharmacological agents. Plast Reconstr Surg 1979; 63: 781.
219. Brouhard BH, Carvajal HF. Effects of inhibiting prostaglandin synthesis on edema formation and albumin leakage during thermal trauma in the rat. Prostaglandins 1979; 17: 940.
220. Fang C. Failure of topical prostaglandin inhibitors to improve wound healing following deep partial-thickness burns. J Trauma 1984; 23: 300.
221. Björnson AB, Knippenberg RW, Björnson HS. Nonsteroidal anti-inflammatory drugs correct the bactericidal defect of polymorphonuclear leukocytes in a guinea pig model of thermal injury. J Infect Dis 1988; 157: 959.
222. Del Beccaro EJ, Robson MC, Heggers JP et al. The use of specific thromboxane inhibitors to preserve the dermal microcirculation after burning. Surgery 1980; 87: 137.
223. Xue RJ, Hammerschmidt DE, Coppo PA et al. Anisodamine inhibits thromboxane synthesis, granulocyte aggregation and platelet aggregation. JAMA 1982; 247: 1458.
224. Yuesheng H, Ao (Ngao) L, Zongcheng Y. Roles of thromboxane and its inhibitor anisodamine in burn shock. Burns 1990; 16: 249.
225. Zawacki BE. Reversal of capillary stasis and prevention of necrosis in burns. Ann Surg 1974; 180: 98.
226. Robson MC, Heggers JP, Hagstrom WJ. Myth, magic, witchcraft, or fact? Aloe vera revisited. J Burn Care Rehabil 1982; 3: 157.
227. Cera LM, Heggers JP, Robson MC et al. The therapeutic efficacy of dermaide aloe in thermal injuries. J Am Anim Hosp Assoc 1980; 16: 768.
228. Heggers JP, Robson MC, Zachary LS. Thromboxane inhibitors for the prevention of progressive dermal ischemia due to the thermal injury. J Burn Care Rehabil 1985; 6: 466.
229. Ehrlich HP, Needle AL, Rajaratnam J et al. The role of prostacyclin and thromboxane in burn and freeze injuries. Exp Mol Pathol 1983; 38: 357.
230. Wang SL, Silberstein EB, Lukes S et al. The effect of thromboxane synthetase inhibitor Dazmegrel (UK-38485) on wound healing, dermal ink perfusion and skin blood flow measurements in deep partial thickness burns. Burns 1986; 12: 312.
231. Kaufman T, Kalderon N, Ullman Y et al. Aloe vera gel hindered wound healing of experimental second-degree burns: a quantitative controlled study. J Burn Care Rehabil 1988; 9: 156.
232. Björk, J, Arturson G. Effect of cimetidine, hydrocortisone, superoxide dismutase and catalase on the development of oedema after thermal injury. Burns 1983; 9: 249.
233. Hambrecht GS, Hilton JG. The effects of catalase, indomethacin and FPL55712 on vascular permeability in the hamster cheek pouch following scald injury. Prostaglandins Leukotrienes Med 1984; 14: 297.
234. Melikian V, Laverson S, Zawacki B. Oxygen derived free radical inhibition in the healing of experimental zone-of-stasis burns. J Trauma 1987; 27: 151.
235. Speakman EA, Chapman BJ. Effect of allopurinol or superoxide dismutase plus catalase on cardiovascular function after burn injury in the anaesthetized rat. Burns 1989; 15: 147.
236. Mingjin Z, Qifang W, Lanxing G et al. Comparative observation of the changes in serum lipid peroxides influenced by the supplementation of vitamin E in burn patients and healthy controls. Burns 1992; 18: 19.
237. Matsuda T, Tanaka H, Williams S et al. Reduced fluid volume requirement for resuscitation of third degree burns using high dose vitamin C. J Burn Care Rehabil 1991; 12: 525.
238. Matsuda T, Tanaka H, Shimazaki S et al. High-dose vitamin C therapy for extensive deep dermal burns. Burns 1992; 18: 127.
239. Takatani M, Maezaki N, Imura Y et al. Platelet activating factor (PAF) antagonist: development of a highly potent PAF antagonist TCV-309. In: Samuelsson B, ed. Advances in Prostaglandin, Thromboxane, and Leukotriene Research, vol 2. New York: Raven Press, 1990; p 425.
240. Ono I, Gunji H, Hasegawa T et al. Effects of a platelet activating factor antagonist on oedema formation following burns. Burns 1993; 19: 202.
241. Anderson BO, Harken AH. Multiple organ failure: inflammatory priming and activation sequences promote autologous tissue injury. J Trauma 1990; 30: (suppl), 44.
242. Bauer JA, Hafner M, Fritz H. Balanced antiinflammation: the combined application of a PAF inhibitor and a cyclooxygenase inhibitor blocks the inflammatory take-off after burns. Int J Tiss Reac 1990; 12: 203.
243. Brown GL, Curtsinger L, Ackerman DM et al. Enhancement of epidermal regeneration by biosynthetic growth factor. J Exp Med 1986; 163: 1319.
244. Schultz GS, White M, Mitchell R et al. Epithelial wound healing enhanced by transforming growth factor alpha and vaccinia growth factor. Science 1987; 235: 350.
245. Hunt TK. Basic principles of wound healing. J Trauma 1990; 30: (suppl), 122.
246. Brown GL, Nanney LB, Griffin J. Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med 1989; 321: 76.
247. Brown GL, Curtsinger L, Jurkiewicz MJ et al. Stimulation of healing of chronic wounds by epidermal growth factor. Plast Reconstr Surg 1991; 88: 189.
248. Herndon DN, Barrow RE, Kunkel KR et al. Effects of recombinant human growth hormone on donor site healing in severely burned children. Ann Surg 1990; 212: 424.
249. Håkansson L, Venge P. The molecular basis of the hyaluronic acid-mediated stimulation of granulocyte function. J Immunol 1987; 138: 4347.
250. Håkansson L, Venge P. The combined action of hyaluronic acid and fibronectin stimulates neutrophil migration. J Immunol 1985; 135: 2735.
251. Häkansson L, Hällgren R, Venge P et al. Hyaluronic acid stimulates neutrophil function in vitro and in vivo. Scand J Infect Dis 1980; 24: 54.
252. Pruitt Jr BA. Progress in burn care - introduction. World J Surg 1992; 16: 1.